BioAtla
encouraging phase results with support advancing into phase in multiple indications | BioAtla
Company
Deck Type
Sector
Industry
Deck date
June 2022
Slide
12 of 15
Related slides by other companies
Adagio Therapeutics
Results
June 2022
results from the phase randomized double blind placebo controlled trial to evaluate the efficacy and safety of in the treatment of ambulatory participants with mild or moderate covid stamp microbe | Adagio Therapeutics
Aeglea BioTherapeutics
Investor Presentation
July 2023
a has emerged as one of the most promising targets in both and | Aeglea BioTherapeutics
9 Meters Biopharma
Investor Presentation
September 2022
vibrant phase summary of results | 9 Meters Biopharma
Oculis
Investor Conference
June 2023
development status | Oculis
Other recent decks by BioAtla
See all presentations (8 decks)
Investor Presentation
January 2024
Investor Presentation
August 2023
Investor Presentation
May 2023
Investor Presentation
November 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io